Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti Epileptic Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112521352A details a novel route for (R)-4-propyl-dihydrofuran-2-one. This method offers cost reduction in API manufacturing and scalable production.
Novel sulfonyl-pyrrolidine route for Brivaracetam. Reduces chiral separation costs and simplifies purification for scalable API manufacturing.
Patent CN112739683B reveals a novel Brivaracetam synthesis using Quinine catalysts. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111170881B reveals high-purity Brivaracetam intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Discover a novel Brivaracetam synthesis method avoiding chiral columns. Enhanced purity, reduced costs, and scalable manufacturing for pharmaceutical intermediates.
Solve high-cost synthesis challenges for Brivaracetam intermediates. New 5-step route with 78% yield reduces raw material costs by 40%—ideal for R&D and procurement teams.
Discover how composite catalysis of 2-cyano-2-valproic acid ester reduces costs and improves purity for valproate production, ensuring supply chain stability.